Back to all people

Qing Xie

FDA

3 appearances in the program

Sessions & presentations

PS34: Patient Reported Outcomes in Small-Size Hematological Clinical Trials: Statistical Challenges and Considerations

Parallel · Fri, Sep 18 , 10:45 AM

Co-Organizer

PS34: Patient Reported Outcomes in Small-Size Hematological Clinical Trials: Statistical Challenges and Considerations

Presentation: Case Sharing for Incorporating PRO Endpoints from Non-malignant Hematological Trial Review Experience

Parallel · Fri, Sep 18 , 10:45 AM

Presenting Author

PS55: Using AI/ML to Integrate Real-World Evidence and Patient-Reported Outcomes in Drug Development for Hematologic Malignancy– Methods and Applications

Presentation: Panel Discussion

Parallel · Fri, Sep 18 , 2:50 PM

Panelist

↑